Patent ID: 8980870
Filing Date: 2015-03-17
Classification: A61K

Abstract:
1. A solid pharmaceutical composition capsule or tablet comprising 3 wt. % to 50 wt. % telmisartan dispersed in a dissolving matrix comprising: (a) a basic agent, selected from NaOH, KOH, NaHCO (b) about 1 wt. % to about 20 wt. % of polyoxamers having an average molecular weight of about 2000 to 12000; (c) 25 wt. % to 70 wt. % of a water-soluble diluent; and (d) 0 wt. % to 20 wt. % of one or more additional excipients and/or adjuvants, wherein the sum of all components is 100%; and wherein the pharmaceutical composition is a solid in the form of a capsule or a tablet.